These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25818893)

  • 1. Colorectal cancer drug target prediction using ontology-based inference and network analysis.
    Tao C; Sun J; Zheng WJ; Chen J; Xu H
    Database (Oxford); 2015; 2015():. PubMed ID: 25818893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of genetic variants and gene network for drug repurposing in colorectal cancer.
    Irham LM; Wong HS; Chou WH; Adikusuma W; Mugiyanto E; Huang WC; Chang WC
    Pharmacol Res; 2020 Nov; 161():105203. PubMed ID: 32950641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of intestinal flora-related key genes and therapeutic drugs in colorectal cancer.
    Zhang J; Zhang H; Li F; Song Z; Li Y; Zhao T
    BMC Med Genomics; 2020 Nov; 13(1):172. PubMed ID: 33198757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel immune-relevant drug target genes for Alzheimer's Disease by combining ontology inference with network analysis.
    Han ZJ; Xue WW; Tao L; Zhu F
    CNS Neurosci Ther; 2018 Dec; 24(12):1253-1263. PubMed ID: 30106219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of key genes in colorectal cancer using random walk with restart.
    Cui X; Shen K; Xie Z; Liu T; Zhang H
    Mol Med Rep; 2017 Feb; 15(2):867-872. PubMed ID: 28000901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNK2 as a key drug target for the treatment of metastatic colorectal cancer.
    Qi L; Ding Y
    Int J Biol Macromol; 2018 Nov; 119():48-52. PubMed ID: 30036625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.
    Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM
    Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics analysis-based screening of circRNA gene with mainstream expression trend in colorectal cancer and construction of a coexpression regulatory network.
    Xu L; Zhang H; Shao Y; Fu Z
    PLoS One; 2023; 18(12):e0295126. PubMed ID: 38064496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of the Anti-Tumor Mechanism of Calycosin Against Colorectal Cancer by Using System Pharmacology Approach.
    Huang C; Li R; Shi W; Huang Z
    Med Sci Monit; 2019 Jul; 25():5589-5593. PubMed ID: 31352466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathway2Targets: an open-source pathway-based approach to repurpose therapeutic drugs and prioritize human targets.
    Dobbs Spendlove M; M Gibson T; McCain S; Stone BC; Gill T; Pickett BE
    PeerJ; 2023; 11():e16088. PubMed ID: 37790614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of multiple oncogenic signaling pathways by Hsp90 inhibitor alone or in combination with berberine for treatment of colorectal cancer.
    Su YH; Tang WC; Cheng YW; Sia P; Huang CC; Lee YC; Jiang HY; Wu MH; Lai IL; Lee JW; Lee KH
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2261-72. PubMed ID: 25982393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A network pharmacology-based investigation on the bioactive ingredients and molecular mechanisms of Gelsemium elegans Benth against colorectal cancer.
    Que W; Chen M; Yang L; Zhang B; Zhao Z; Liu M; Cheng Y; Qiu H
    BMC Complement Med Ther; 2021 Mar; 21(1):99. PubMed ID: 33743701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding apoptotic induction by Sargentodoxa cuneata-Patrinia villosa herb pair via PI3K/AKT/mTOR signalling in colorectal cancer cells using network pharmacology and cellular studies.
    Mu BX; Li Y; Ye N; Liu S; Zou X; Qian J; Wu C; Zhuang Y; Chen M; Zhou JY
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117342. PubMed ID: 37879505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic targeting of the TPX2/TTK network in colorectal cancer.
    Shaath H; Vishnubalaji R; Elango R; Velayutham D; Jithesh PV; Alajez NM
    Cell Commun Signal; 2023 Sep; 21(1):265. PubMed ID: 37770979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
    Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
    Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ToP: a trend-of-disease-progression procedure works well for identifying cancer genes from multi-state cohort gene expression data for human colorectal cancer.
    Chung FH; Lee HH; Lee HC
    PLoS One; 2013; 8(6):e65683. PubMed ID: 23799036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A computer-aided drug design approach to discover tumour suppressor p53 protein activators for colorectal cancer therapy.
    Patrício RPS; Videira PA; Pereira F
    Bioorg Med Chem; 2022 Jan; 53():116530. PubMed ID: 34861473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOXB7 and Hsa-miR-222 as the Potential Therapeutic Candidates for Metastatic Colorectal Cancer.
    Iman M; Mostafavi SS; Arab SS; Azimzadeh S; Poorebrahim M
    Recent Pat Anticancer Drug Discov; 2016; 11(4):434-443. PubMed ID: 27855613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
    Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network Pharmacology-Based Prediction and Verification of the Active Ingredients and Potential Targets of Zuojinwan for Treating Colorectal Cancer.
    Huang S; Zhang Z; Li W; Kong F; Yi P; Huang J; Mao D; Peng W; Zhang S
    Drug Des Devel Ther; 2020; 14():2725-2740. PubMed ID: 32764874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.